This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Alethia BioTherapeutics Inc.
Drug Names(s): AB-3A4
Description: AB-3A4 is a monoclonal anitbody drug conjugate (ADC) that inhibits tumor progression and invasion. It targets KAAG-1, a cell-surface protein expressed in >90% of ovarian tumors and few normal tissues.
Additional information available to subscribers only: